ArticleDiseases (Basel, Switzerland)2026

Prospective Bi-Centric Real-World Outcomes of Upadacitinib in Biologic-Experienced Patients with Crohn's Disease.

Janina Lüke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.